User:Mr. Ibrahem/Regorafenib

Regorafenib, sold under the brand name Stivarga among others, is a medication used to treat colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular cancer. It is used after other treatments have failed. It is taken by mouth.

Common side effects include pain, tiredness, rash, diarrhea, infection, and high blood pressure. Other side effects may include liver problems, bleeding, and gastrointestinal perforation. It is a protein kinase inhibitor including the VEGF receptors and FGF receptors.

Regorafenib was approved for medical use in the United States in 2012 and Europe in 2013. In the United Kingdom 4 weeks of treatment costs the NHS about £3,750 as of 2021. In the United States this amount costs about 19,600 USD.